Glyphosate on trial: Bayer would consider settling all cancer lawsuits on ‘reasonable terms’, as suits now number 18,400

| | July 31, 2019
Screen Shot at AM
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Bayer on [July 30] said it would consider settling with U.S. plaintiffs suing over the German group’s Roundup herbicide only on reasonable terms, and if such a move wraps up all cases.

Bayer said the number of U.S. plaintiffs blaming Roundup and other glyphosate-based weedkillers for their cancer continued to rise by 5,000 to 18,400….

Read full, original article: Bayer sees glyphosate settlement only if financially reasonable

Related article:  Anti-GMO Advocacy Funding Tracker: Vast network of donors and NGOs seed doubt about crop biotechnology
Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend